chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site cellulitis
Clinical narrative: red; hard; cellulitis at the injection site; hot; tender; itchy; This spontaneous case was reported by a patient and describes the occurrence of SKIN WARM (hot), PAIN OF SKIN (tender), PRURITUS (itchy), ERYTHEMA (red) and INDURATION (hard) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced SKIN WARM (hot), PAIN OF SKIN (tender) and PRURITUS (itchy). On 22-Jan-2021, the patient experienced ERYTHEMA (red), INDURATION (hard) and VACCINATION SITE CELLULITIS (cellulitis at the injection site). On 15-Jan-2021, PAIN OF SKIN (tender) had resolved. At the time of the report, SKIN WARM (hot), ERYTHEMA (red), INDURATION (hard) and VACCINATION SITE CELLULITIS (cellulitis at the injection site) outcome was unknown and PRURITUS (itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient went to urgent care after her symptoms returned and started worsening. They diagnosed her with cellulitis at the injection site and prescribed her Bactrim topical ointment and doxycycline oral.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: Additional information included further details regarding the events, and additional patient information.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Urticaria; injection site was very itchy; dark red rash; dark red rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (Urticaria) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Urticaria). At the time of the report, URTICARIA (Urticaria) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Topical antihistamines were recommended as treatment.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Myalgia, Vaccination complication
Clinical narrative: I felt like I had covid again; A whole night of not sleeping; Head hurt; My body hurt; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt). At the time of the report, VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Hypoaesthesia, Muscle tightness, Oral discomfort, Throat irritation
Clinical narrative: muscle tightness in my shoulder up to my neck; She experienced numbness on her face in the cheek and bottom part of her chin; coolness in her mouth; experienced burning in her throat; light burning in her chest; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck), HYPOAESTHESIA (She experienced numbness on her face in the cheek and bottom part of her chin), ORAL DISCOMFORT (coolness in her mouth), THROAT IRRITATION (experienced burning in her throat) and CHEST PAIN (light burning in her chest) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021 at 11:39 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck), HYPOAESTHESIA (She experienced numbness on her face in the cheek and bottom part of her chin), ORAL DISCOMFORT (coolness in her mouth), THROAT IRRITATION (experienced burning in her throat) and CHEST PAIN (light burning in her chest). On 21-Jan-2021, HYPOAESTHESIA (She experienced numbness on her face in the cheek and bottom part of her chin), ORAL DISCOMFORT (coolness in her mouth), THROAT IRRITATION (experienced burning in her throat) and CHEST PAIN (light burning in her chest) had resolved. On 22-Jan-2021, MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site exfoliation, Vaccination site pruritus, Vaccination site rash
Clinical narrative: dark red rash that was very itchy; dark red rash that was very itchy; itchy; Skin peeling at injection site; This spontaneous case was reported by a nurse and describes the occurrence of   in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   The patient was recommended to use a topical antihistamine for treatment of the events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site warmth, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: Little bit of tingling in both arms; Little bit of soreness in arm; Warm; Slight headache; Fever; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Little bit of tingling in both arms), PAIN IN EXTREMITY (Little bit of soreness in arm), INJECTION SITE WARMTH (Warm), HEADACHE (Slight headache) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN, ROSUVASTATIN and OXYBUTYNIN for an unknown indication.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Little bit of tingling in both arms), PAIN IN EXTREMITY (Little bit of soreness in arm), INJECTION SITE WARMTH (Warm), HEADACHE (Slight headache) and PYREXIA (Fever). At the time of the report, PARAESTHESIA (Little bit of tingling in both arms), PAIN IN EXTREMITY (Little bit of soreness in arm), INJECTION SITE WARMTH (Warm), HEADACHE (Slight headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Got rash 3 days after the vaccine; This spontaneous case was reported by a patient and describes the occurrence of RASH (Got rash 3 days after the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Got rash 3 days after the vaccine). At the time of the report, RASH (Got rash 3 days after the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Nasal congestion, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Found out he had COVID; Runny nose; Stuffy and runny nose; Sneezing; Stuffy and runny nose; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Found out he had COVID), RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing) and RHINORRHOEA (Stuffy and runny nose) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 102L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced COVID-19 (Found out he had COVID), RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing), RHINORRHOEA (Stuffy and runny nose) and FATIGUE (Fatigue). At the time of the report, COVID-19 (Found out he had COVID) outcome was unknown and RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing), RHINORRHOEA (Stuffy and runny nose) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Date of the test is not provided. and negative (Negative) Date of the test is not provided..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   The patient took emergenC for treatment of the events.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: Found out he had COVID; Runny nose; Stuffy and runny nose; Sneezing; Stuffy and runny nose; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Found out he had COVID), RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing) and RHINORRHOEA (Stuffy and runny nose) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 102L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced COVID-19 (Found out he had COVID), RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing), RHINORRHOEA (Stuffy and runny nose) and FATIGUE (Fatigue). At the time of the report, COVID-19 (Found out he had COVID) outcome was unknown and RHINORRHOEA (Runny nose), NASAL CONGESTION (Stuffy and runny nose), SNEEZING (Sneezing), RHINORRHOEA (Stuffy and runny nose) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Date of the test is not provided. and negative (Negative) Date of the test is not provided..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   The patient took emergenC for treatment of the events.
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient did not receive any treatment.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Injected limb mobility decreased, Pain in extremity, Paraesthesia
Clinical narrative: tingling in the arm; Pain/ hurt a lot; Can't move arm; Panicking as never got pain like this; Chills; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (Panicking as never got pain like this) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 126L20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 21-Jan-2021 at 5:55 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ANXIETY (Panicking as never got pain like this). At the time of the report, ANXIETY (Panicking as never got pain like this) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot to the touch at the injection site; red; Swelling; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch at the injection site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (Swelling) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch at the injection site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE WARMTH (hot to the touch at the injection site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient sought treatment from a doctor and she was prescribed cephalexin, but had not started taking it at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives on 12th dayand 15th day after vaccine; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (hives on 12th dayand 15th day after vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced URTICARIA (hives on 12th dayand 15th day after vaccine). At the time of the report, URTICARIA (hives on 12th dayand 15th day after vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information provided.    Reporter did not allow further contact
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Heart rate, Pyrexia, Tachycardia, Vomiting
Clinical narrative: rapid heartbeat around 120; diarrhea; low-grade fever; vomiting; This spontaneous case was reported by a nurse and describes the occurrence of TACHYCARDIA (rapid heartbeat around 120), DIARRHOEA (diarrhea), PYREXIA (low-grade fever) and VOMITING (vomiting) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (rapid heartbeat around 120), DIARRHOEA (diarrhea), PYREXIA (low-grade fever) and VOMITING (vomiting). At the time of the report, TACHYCARDIA (rapid heartbeat around 120), DIARRHOEA (diarrhea), PYREXIA (low-grade fever) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: around 120 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Hypoaesthesia, Pruritus, Swelling face
Clinical narrative: swelling face, mouth, lips; swelling of face, tongue; Itching; From my lips and left ear, down my jaw I am numb; face and neck turned red/hand are itching and red; hives all over body; Allergic reaction; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb) and ERYTHEMA (face and neck turned red/hand are itching and red) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb), ERYTHEMA (face and neck turned red/hand are itching and red), URTICARIA (hives all over body) and HYPERSENSITIVITY (Allergic reaction). At the time of the report, SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb), ERYTHEMA (face and neck turned red/hand are itching and red), URTICARIA (hives all over body) and HYPERSENSITIVITY (Allergic reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient was given Benadryl after the initial onset of the events. 5 hours after taking Benadryl, the events returned and the patient took another dose of Benadryl.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Urticaria
Clinical narrative: swelling face, mouth, lips; swelling of face, tongue; Itching; From my lips and left ear, down my jaw I am numb; face and neck turned red/hand are itching and red; hives all over body; Allergic reaction; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb) and ERYTHEMA (face and neck turned red/hand are itching and red) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb), ERYTHEMA (face and neck turned red/hand are itching and red), URTICARIA (hives all over body) and HYPERSENSITIVITY (Allergic reaction). At the time of the report, SWELLING FACE (swelling face, mouth, lips), SWOLLEN TONGUE (swelling of face, tongue), PRURITUS (Itching), HYPOAESTHESIA (From my lips and left ear, down my jaw I am numb), ERYTHEMA (face and neck turned red/hand are itching and red), URTICARIA (hives all over body) and HYPERSENSITIVITY (Allergic reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient was given Benadryl after the initial onset of the events. 5 hours after taking Benadryl, the events returned and the patient took another dose of Benadryl.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema
Clinical narrative: Itching; Redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Redness on the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (Redness on the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH RELIEF) (topical) at a dose of UNK dosage form. On 03-Feb-2021, PRURITUS (Itching) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness on the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Additional information received, provides outcome of the event and second dosage information was updated.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Somnolence
Clinical narrative: His arm was hurting real bad.; sleepy; He felt real tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (His arm was hurting real bad.), SOMNOLENCE (sleepy) and FATIGUE (He felt real tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (His arm was hurting real bad.), SOMNOLENCE (sleepy) and FATIGUE (He felt real tired). At the time of the report, PAIN IN EXTREMITY (His arm was hurting real bad.), SOMNOLENCE (sleepy) and FATIGUE (He felt real tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: Spots on back; This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (Spots on back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus erythematosus.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced RASH MACULAR (Spots on back). At the time of the report, RASH MACULAR (Spots on back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient used an unspecified steroid cream as treatment for the event.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Rash below the injection site; Soreness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (Rash below the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash below the injection site) and VACCINATION SITE PAIN (Soreness at the injection site). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 28-Jan-2021 for Vaccination site rash and Vaccination site pain, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE RASH (Rash below the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia, Vaccination site erythema
Clinical narrative: Injection site pain; Redness; Swelling; Fever; Fatigue; Aches; Chills; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included LISINOPRIL for an unknown indication.    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Aches) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Aches) and CHILLS (Chills) outcome was unknown.            No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site pain; Redness; Swelling; Fever; Fatigue; Aches; Chills; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included LISINOPRIL for an unknown indication.    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Aches) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Aches) and CHILLS (Chills) outcome was unknown.            No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Diarrhoea, Headache, Myalgia
Clinical narrative: Diarrhea; Severe muscle and joint pain; Severe muscle and joint pain; Fever; Headache; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (took 5 weeks to have negative covid test) and Pneumonia (2 months ago). Concurrent medical conditions included Iodine allergy, Blood pressure high and Vascular disorder NOS. Concomitant products included ATENOLOL for Blood pressure high.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) on 22-Jan-2021 at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: systolic 170 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Diarrhea; Severe muscle and joint pain; Severe muscle and joint pain; Fever; Headache; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (took 5 weeks to have negative covid test) and Pneumonia (2 months ago). Concurrent medical conditions included Iodine allergy, Blood pressure high and Vascular disorder NOS. Concomitant products included ATENOLOL for Blood pressure high.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) on 22-Jan-2021 at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIARRHOEA (Diarrhea), MYALGIA (Severe muscle and joint pain), ARTHRALGIA (Severe muscle and joint pain), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: systolic 170 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Lymph node pain, Lymphadenopathy, Maternal exposure during breast feeding, Pain in extremity
Clinical narrative: Swollen lymph nodes on left side of neck; Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain; Exposure during breast feeding; Dizziness; Arm pain; This spontaneous case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding), DIZZINESS (Dizziness), PAIN IN EXTREMITY (Arm pain), LYMPHADENOPATHY (Swollen lymph nodes on left side of neck) and LYMPH NODE PAIN (Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding), DIZZINESS (Dizziness) and PAIN IN EXTREMITY (Arm pain). On 13-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes on left side of neck) and LYMPH NODE PAIN (Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain). On 11-Jan-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (Exposure during breast feeding) had resolved. On 12-Jan-2021, DIZZINESS (Dizziness) and PAIN IN EXTREMITY (Arm pain) had resolved. On 14-Jan-2021, LYMPH NODE PAIN (Lymph node swelling on left side of neck was noticed on 13Jan2021 with some pain) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes on left side of neck) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.    This case was linked to MOD-2021-013243 (Parent-Child Link).   See case MOD-2021-013243 for details regarding the child case.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Hyperhidrosis
Clinical narrative: Chest Pain; Bad sweat from head to toe; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Chest Pain) and HYPERHIDROSIS (Bad sweat from head to toe) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPERHIDROSIS (Bad sweat from head to toe). On an unknown date, the patient experienced CHEST PAIN (Chest Pain). At the time of the report, CHEST PAIN (Chest Pain) and HYPERHIDROSIS (Bad sweat from head to toe) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Pruritus
Clinical narrative: Flushing; Itching; This spontaneous case was reported by an other health care professional and describes the occurrence of FLUSHING (Flushing) and PRURITUS (Itching) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Migraine. Concurrent medical conditions included Hyperlipidemia, Penicillin allergy and Drug allergy (Sulfa allergy). Concomitant products included EPINEPHRINE and DEXAMETHASONE for an unknown indication.   On 29-Jan-2021 at 4:55 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021 at 5:00 PM, the patient experienced FLUSHING (Flushing) and PRURITUS (Itching). At the time of the report, FLUSHING (Flushing) and PRURITUS (Itching) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was reported to receive epinephrine and dexamethasone in the clinic prior to arrival. Patient was reported to be treated with intravenous fluids, dose of corticosteroids and H1 and H2 blockers in the emergency department. On discharge, he patient was asked to continue Benadryl (diphenhydramine hydrochloride) if needed. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: itch around injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (itch around injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itch around injection site). At the time of the report, VACCINATION SITE PRURITUS (itch around injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  The patient did not receive any treatment for the event.    Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Vaccination site pain
Clinical narrative: sore throat; sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headache) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment medications were reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Discomfort, Headache, Limb discomfort, Nightmare
Clinical narrative: Diarrhea comes and goes; Heavy nightmares; Palpitations; Body has felt a little off; Bad headaches; Arm felt heavy and painful; Arm felt heavy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and PAIN IN EXTREMITY (Arm felt heavy and painful) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (darvacet and darvan.) and Blood pressure high. Concomitant products included LOSARTAN, VITAMIN D3 and CORTISONE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy) and PYREXIA (Fever). On 15-Jan-2021, the patient experienced DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and HEADACHE (Bad headaches). At the time of the report, DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off), PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy), PYREXIA (Fever) and HEADACHE (Bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations, Pyrexia
Clinical narrative: Diarrhea comes and goes; Heavy nightmares; Palpitations; Body has felt a little off; Bad headaches; Arm felt heavy and painful; Arm felt heavy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and PAIN IN EXTREMITY (Arm felt heavy and painful) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (darvacet and darvan.) and Blood pressure high. Concomitant products included LOSARTAN, VITAMIN D3 and CORTISONE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy) and PYREXIA (Fever). On 15-Jan-2021, the patient experienced DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off) and HEADACHE (Bad headaches). At the time of the report, DIARRHOEA (Diarrhea comes and goes), NIGHTMARE (Heavy nightmares), PALPITATIONS (Palpitations), DISCOMFORT (Body has felt a little off), PAIN IN EXTREMITY (Arm felt heavy and painful), LIMB DISCOMFORT (Arm felt heavy), PYREXIA (Fever) and HEADACHE (Bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: Tingling sensation that went up her neck and onto her cheek; tingling sensation that was itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling sensation that went up her neck and onto her cheek) and PRURITUS (tingling sensation that was itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN and VITAMINS NOS for an unknown indication.    On 21-Jan-2021 at 4:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021 at 8:00 PM, the patient experienced PARAESTHESIA (Tingling sensation that went up her neck and onto her cheek) and PRURITUS (tingling sensation that was itchy). At the time of the report, PARAESTHESIA (Tingling sensation that went up her neck and onto her cheek) and PRURITUS (tingling sensation that was itchy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment details provided for the patient were-on 21Jan2021 patient took loratadine and on 22Jan2021- patient took diphenhydramine.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Vaccination site pain
Clinical narrative: Body aches; soreness in arm; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), VACCINATION SITE PAIN (soreness in arm), HEADACHE (headache) and CHILLS (chills) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 23-Jan-2021, the patient experienced PAIN (Body aches), VACCINATION SITE PAIN (soreness in arm), HEADACHE (headache) and CHILLS (chills). At the time of the report, PAIN (Body aches), VACCINATION SITE PAIN (soreness in arm), HEADACHE (headache) and CHILLS (chills) had resolved.            No relevant concomitant medications were reported Treatment medications used were ibuprofen and acetaminophen
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: 8 days after shot woke up with an itchy injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (8 days after shot woke up with an itchy injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (8 days after shot woke up with an itchy injection site). At the time of the report, VACCINATION SITE PRURITUS (8 days after shot woke up with an itchy injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No information on concomitant or treatment medications was reported   Reporter did not allow further contact